Posted by Michael Wonder on 10 Jul 2021
Application for cystic fibrosis medicine received by PHARMAC
9 July 2021 - PHARMAC is starting its funding assessment process for a new cystic fibrosis medication after receiving an application from Vertex.
Vertex has applied for its triple combination modulator therapy medicine to be funded for people aged over 6 with cystic fibrosis, making New Zealand the first country to receive an application for those under the age of 12.
